F98 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - CytoMed Therapeutics Ltd

Watchlist Manager

Watchlist

Price: 0.7 EUR -14.63%

Market Cap: €8.2m

	CytoMed Therapeutics Ltd F:F98	SG
F	Food and Drinks PCL SET:F&D	TH
O	Optimind Pharma Corp CNSX:OMND	CA
B	BCPG PCL SET:BCPG	TH
G	Green Tech Ventures PCL SET:GTV	TH
F	Futebol Clube do Porto Futebol Sad XMUN:FBC	PT
C	Coloseum Holding as PSE:COLOS	CZ
I	Islandsbanki hf ICEX:ISB	IS
G	Getabec PCL SET:GTB	TH
A	Asset World Corp PCL SET:AWC	TH
U	US Critical Metals Corp CNSX:USCM	CA
M	MetroGAS SA BCBA:METR	AR
	DFDS A/S CSE:DFDS	DK
F	Fastenal Co F:FAS	US
B	Bezvavlasy as PSE:BEZVA	CZ

Profitability Summary

CytoMed Therapeutics Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

97%

Strong 3Y Average Gross Margin

64%

Negative Operating Margin

-1 228%

Negative 3Y Average Operating Margin

-1 870%

Negative Net Margin

-1 076%

Negative 3Y Average Net Margin

-1 888%

Negative Free Cash Flow Margin

-1 315%

Negative 3Y Average Free Cash Flow Margin

-2 633%

Negative ROE

-58%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-79%

ROIC is Increasing

-121% > -73%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.